Navigation Links
Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
Date:2/9/2011

umerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cephalon.com/.

About Alba Therapeutics CorporationAlba Therapeutics Corporation ("Alba") is a Baltimore, Maryland privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases.  

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any su
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
2. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
3. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
4. Cephalon to Webcast Investor Day
5. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
6. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
7. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
8. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
9. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
10. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
11. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
(Date:11/21/2014)... SARASOTA, Fla. , Nov. 21, 2014   ... ) announced that the Company is scheduled to present ... San Francisco, CA on January 12-14, ... PhD, Chairman and CEO of Rock Creek Pharmaceuticals, will ... small molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. ...
(Date:11/21/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... to acquire 100% of QCR & Trio Diagnostics Limited, ... organization. The transaction closed on November 17, 2014. ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... DUBLIN, October 18, 2010 ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... the PRECiSE 3 (P3) open label extension study for ... maintenance trial for an anti-TNF in Crohn,s disease, will ... the American College of Gastroenterology (ACG), taking place in ... efficacy data from the PRECiSE 4 (P4) clinical trial ...
Cached Medicine Technology:Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 2Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 3Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 4Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 5Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 6Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 7UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 2UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 3UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 4UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 5UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 6UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 7UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 8UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 9UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 10UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 11
(Date:11/22/2014)... A new AlignLife Chiropractic & Natural ... downtown Greenville area. Dr. Chelsea Sineath, owner and chiropractor ... open her own clinic after working in another AlignLife ... , AlignLife believes that the body can heal ... on chiropractic care and rehabilitation to allow the spine ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress company, has recently ... can buy new dresses at its online shop now. ... , As a matter of fact, PrettyTailor specializes in ... four types of wedding outfits, including bridesmaid dresses, mother ... also provides a variety of occasion dresses, such as ...
(Date:11/22/2014)... A classic black prom dress will never go out ... has unveiled its new items of black prom gowns ... a big discount, up to 70% off. People throughout the ... black prom dresses, made with the best materials, can make ... all customers, the company provides these beautiful outfits in a ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 BambooFlooringChina.com ... the company has proudly released its new collection of ... discounted rates, up to 29% off. , According ... and sturdy tree-like grass, making it a highly renewable resource. ... products have a mixing color which comes from natural bamboo ...
(Date:11/22/2014)... York, NY (PRWEB) November 22, 2014 ... Therapeutics Goods Administration (TGA) approved it for use ... was approved and listed within the Therapeutic Goods ... http://www.comlaw.gov.au/Details/F2014L01277 , Kyowa Hakko’s Setria® Glutathione will ... a biotech specialist that sources and imports fine ...
Breaking Medicine News(10 mins):Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3
... 26 The AMERIGROUP Foundation,today announced that Senator ... its "Champion for Children" award., The award ... outstanding public advocacy efforts by government and community,leaders ... "Our goal is to work together with ...
... a company,developing breakthrough molecular imaging agents for ... it has entered into a licensing,agreement with ... and,commercialization of agents for diagnosis and treatment ... were co-developed by,FluoroPharma and MGH scientists, target ...
... plagues African populations , , WEDNESDAY, March 26 (HealthDay News) ... from the environment the organism that causes devastating and ... according to a new report. , The study ... idea that the organism, Mycobacterium ulcerans , is ...
... Partnership Develops First-Ever Toolkits to Address ,The ... in America Today, SACRAMENTO, Calif., March 26 ... activities, the California Association of,Health Plans (CAHP) and ... up to encourage physicians to discuss healthier,lifestyles with ...
... by the National Oncologic PET Registry (NOPR) showing that ... a molecular level, which then caused physicians to change ... has corroborated decades of nuclear medicine research. , These ... some time: molecular imaging is a powerful tool in ...
... Corporation will host,their second annual medical device ... in Bedford, Massachusetts., (Logo: http://www.newscom.com/cgi-bin/prnh/20071228/TOXIKONLOGO ... to be updated and revised,medical device manufacturers ... product. With new innovations and applications in,development, ...
Cached Medicine News:Health News:Texas Senator Kirk Watson Honored as 'Champion for Children' by the AMERIGROUP Foundation 2Health News:FluoroPharma Inc. Expands Technology Platform to Include Agents for Alzheimer's Disease (AD) 2Health News:Scientists Isolate Organism That Causes Disfiguring Tropical Disease 2Health News:California Association of Health Plans & California Medical Association Foundation Team Up to Combat Obesity 2Health News:California Association of Health Plans & California Medical Association Foundation Team Up to Combat Obesity 3Health News:California Association of Health Plans & California Medical Association Foundation Team Up to Combat Obesity 4Health News:PET confirmed as valuable cancer diagnostic and disease-staging tool 2
Carbo-Seal Valsalva AAP is the first valved graft to replicate the natural Sinus of Valsalva, encouraging the natural formation of systolic vortices....
... for this technique is acquired tricuspid ... for tricuspid repair are based on ... diagnosed by angiography and dye dilution ... patients with an irreversible tricuspid insufficiency, ...
Current annuloplasty rings and bands are designed for symmetric dilatation. The IMR ETlogix ring is the first asymmetric ring designed to treat asymmetric dilatation....
PremierEdge™ Stab Knives - 45°....
Medicine Products: